ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.60
-0.34%
US Tech 100
17,650.00
0.05%
S&P 500
5,222.68
0.16%
US Dollar vs CAD
1.36818
0.02%
Bitcoin
60,911.33
-0.87%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Innoviva Inc (INVA)

  7. Innoviva Inc (INVA) News

INVA

Innoviva (INVA)

Innoviva Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INVA
DateTimeSourceHeadlineSymbolCompany
05/08/20243:46PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVAInnoviva Inc
05/08/20243:44PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
05/08/20243:05PMBusiness WireInnoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
05/08/20246:00AMBusiness WireInnoviva to Participate in the BofA Securities Health Care ConferenceNASDAQ:INVAInnoviva Inc
04/24/20246:00AMBusiness WireInnoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024NASDAQ:INVAInnoviva Inc
03/07/20246:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
03/07/20246:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
03/07/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
03/07/20245:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
02/29/20244:01PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INVAInnoviva Inc
02/29/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
02/29/20243:05PMBusiness WireInnoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
02/22/20248:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
02/22/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
02/14/20246:23AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVAInnoviva Inc
01/22/20248:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
01/22/20241:03PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVAInnoviva Inc
01/10/20247:26PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
11/17/20233:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
11/06/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
11/01/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
11/01/20233:15PMBusiness WireInnoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
11/01/20233:05PMBusiness WirePositive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated GonorrheaNASDAQ:INVAInnoviva Inc
09/19/20237:30AMBusiness WireInnoviva to Participate in the Cantor Global Healthcare ConferenceNASDAQ:INVAInnoviva Inc
09/18/20237:00AMBusiness WireXACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in AdultsNASDAQ:INVAInnoviva Inc
08/31/20237:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
08/31/20237:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
08/31/20237:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
08/31/20237:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
08/31/20237:10PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
 Showing the most relevant articles for your search:NASDAQ:INVA

Your Recent History

TSXV
SNM
ShaMaran Petroleum
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved